Novartis AG
Nucleic Acids Encoding FGF21-Fc Fusion Proteins
Last updated:
Abstract:
The invention relates to the identification of fusion proteins comprising polypeptide and protein variants of fibroblast growth factor 21 (FGF21) with improved pharmaceutical properties. Also disclosed are methods for treating FGF21-associated disorders, including metabolic conditions.
Status:
Application
Type:
Utility
Filling date:
24 Aug 2021
Issue date:
16 Dec 2021